Petros Pharmaceuticals, Inc.
PTPI
$0.032
$0.00082.56%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.93M | 3.71M | 3.89M | 7.46M | 11.08M |
| Total Receivables | -- | 416.10K | 1.95M | 1.78M | 1.96M |
| Inventory | -- | 3.00M | 3.05M | 2.85M | 2.74M |
| Prepaid Expenses | 53.40K | 162.70K | 404.20K | 628.10K | 1.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.48M | 6.50K | 1.42M | 1.27M | 1.03M |
| Total Current Assets | 14.47M | 7.29M | 10.72M | 13.98M | 17.90M |
|
|
|||||
| Total Current Assets | 14.47M | 7.29M | 10.72M | 13.98M | 17.90M |
| Net Property, Plant & Equipment | -- | 136.70K | 143.70K | 177.60K | 217.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 3.20M | 6.83M | 7.54M | 8.26M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.14M | -- | 3.00M | 3.47M | 3.94M |
| Total Assets | 17.61M | 10.64M | 20.69M | 25.17M | 30.31M |
|
|
|||||
| Total Accounts Payable | 756.70K | 2.33M | 1.60M | 791.10K | 2.14M |
| Total Accrued Expenses | 199.70K | 1.29M | 1.24M | 1.73M | 1.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 7.31M | 2.33M | 1.94M | 1.55M |
| Total Finance Division Other Current Liabilities | 26.18M | 7.10M | 7.40M | 5.52M | 5.77M |
| Total Other Current Liabilities | 26.18M | 7.10M | 7.40M | 5.52M | 5.77M |
| Total Current Liabilities | 27.13M | 18.03M | 12.56M | 9.98M | 11.22M |
|
|
|||||
| Total Current Liabilities | 27.13M | 18.03M | 12.56M | 9.98M | 11.22M |
| Long-Term Debt | -- | -- | 4.92M | 5.70M | 6.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 75.20K | 91.80K | 107.80K | 123.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 57.60K | -- | -- | 202.00K | 1.82M |
| Total Liabilities | 27.19M | 18.10M | 17.58M | 15.98M | 19.62M |
|
|
|||||
| Common Stock & APIC | 105.88M | 105.74M | 107.05M | 109.78M | 110.84M |
| Retained Earnings | -115.47M | -113.21M | -103.93M | -101.71M | -101.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.58M | -7.47M | 3.12M | 8.07M | 9.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 1.40K | 1.12M | 907.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 1.40K | 1.12M | 907.00K |
|
|
|||||
| Total Common Equity | -9.58M | -7.47M | 3.12M | 8.07M | 9.79M |
| Total Preferred Equity | -- | -- | 1.40K | 1.12M | 907.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.58M | -7.47M | 3.12M | 9.19M | 10.69M |
|
|
|||||